Skeletal muscle AMP kinase as a target to prevent pathogenesis of Type 2 diabetes

References

• Zierath JR, He L, Guma A et al. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia39(10), 1180–1189 (1996).
   PubMed Web of Science ®Google Scholar
• Shepherd PR, Nave BT, Rincon J et al. Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle. J. Biol. Chem.272(30), 19000–19007 (1997).
   PubMedGoogle Scholar
• Krook A, Bjornholm M, Galuska D et al. Characterization of signal transduction and glucose transport in skeletal muscle from Type 2 diabetic patients. Diabetes49(2), 284–292 (2000).
   PubMed Web of Science ®Google Scholar
• Bjornholm M, Kawano Y, Lehtihet M, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes46(3), 524–527 (1997).
   PubMed Web of Science ®Google Scholar
• Koistinen HA, Galuska D, Chibalin AV et al. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with Type 2 diabetes. Diabetes52(5), 1066–1072 (2003).
   PubMed Web of Science ®Google Scholar
• Ryder JW, Fahlman R, Wallberg-Henriksson H et al. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement of the mitogen- and stress-activated protein kinase 1. J. Biol. Chem.275(2), 1457–1462 (2000).
   PubMed Web of Science ®Google Scholar
• Storgaard H, Song XM, Jensen CB et al. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of Type 2 diabetic patients [corrected]. Diabetes50(12), 2770–2778 (2001).
   PubMed Web of Science ®Google Scholar
• Karlsson HK, Hallsten K, Bjornholm M et al. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed Type 2 diabetes: a randomized controlled study. Diabetes54(5), 1459–1467 (2005).
   PubMed Web of Science ®Google Scholar
• Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S. The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003. Diabet. Med.22(10), 1420–1426 (2005).
   Google Scholar
• Eliasson B, Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbjornsdottir S. Antihyperglycaemic treatment of Type 2 diabetes: results from a national diabetes register. Diabetes Metab. (2007) (Epub ahead of print).
   Google Scholar
• Chibalin AV, Yu M, Ryder JW et al. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Proc. Natl Acad. Sci. USA97(1), 38–43 (2000).
   PubMed Web of Science ®Google Scholar
• Yu M, Blomstrand E, Chibalin AV et al. Exercise-associated differences in an array of proteins involved in signal transduction and glucose transport. J. Appl. Physiol.90(1), 29–34 (2001).
   PubMed Web of Science ®Google Scholar
• Holloszy JO. Exercise-induced increase in muscle insulin sensitivity. J. Appl. Physiol.99(1), 338–343 (2005).
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Goodyear LJ. Exercise effects on muscle insulin signaling and action: invited review: intracellular signaling in contracting skeletal muscle. J. Appl. Physiol.93(1), 369–383 (2002).
   PubMed Web of Science ®Google Scholar
• Long YC, Widegren U, Zierath JR. Exercise-induced mitogen-activated protein kinase signalling in skeletal muscle. Proc. Nutr. Soc.63(2), 227–232 (2004).
   PubMed Web of Science ®Google Scholar
• Hawley JA, Hargreaves M, Zierath JR. Signalling mechanisms in skeletal muscle: role in substrate selection and muscle adaptation. Essays Biochem.42, 1–12 (2006).
   PubMed Web of Science ®Google Scholar
• Zierath JR. Invited review: exercise training-induced changes in insulin signaling in skeletal muscle. J. Appl. Physiol.93(2), 773–781 (2002).
   PubMed Web of Science ®Google Scholar
• Teran-Garcia M, Rankinen T, Koza RA, Rao DC, Bouchard C. Endurance training-induced changes in insulin sensitivity and gene expression. Am. J. Physiol. Endocrinol. Metab.288(6), E1168–E1178 (2005).
   Google Scholar
• Widegren U, Jiang XJ, Krook A et al. Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB J.12(13), 1379–1389 (1998).
   PubMed Web of Science ®Google Scholar
• Yu M, Blomstrand E, Chibalin AV, Krook A, Zierath JR. Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. J. Physiol.536(Pt 1), 273–282 (2001).
   PubMedGoogle Scholar
• Krook A, Widegren U, Jiang XJ et al. Effects of exercise on mitogen- and stress-activated kinase signal transduction in human skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol.279(5), R1716–R1721 (2000).
   PubMed Web of Science ®Google Scholar
• Niu W, Huang C, Nawaz Z et al. Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. J. Biol. Chem.278(20), 17953–17962 (2003).
   Google Scholar
• Koistinen HA, Chibalin AV, Zierath JR. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients. Diabetologia46(10), 1324–1328 (2003).
   Google Scholar
• Al-Khalili L, Chibalin AV, Yu M et al. MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am. J. Physiol. Cell Physiol.286, C1410–C1416 (2004).
   Google Scholar
• Thai MV, Guruswamy S, Cao KT, Pessin JE, Olson AL. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J. Biol. Chem.273(23), 14285–14292 (1998).
   PubMed Web of Science ®Google Scholar
• Fiedler M, Zierath JR, Selen G et al. 5-aminoimidazole-4-carboxy-amide-1-β-d-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice. Diabetologia44(12), 2180–2186 (2001).
   Google Scholar
• Song XM, Fiedler M, Galuska D et al. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia45(1), 56–65 (2002).
   PubMed Web of Science ®Google Scholar
• Hardie DG. AMP-activated protein kinase as a drug target. Ann. Rev. Pharmacol. Toxicol.47(1), 185–210 (2007).
   PubMed Web of Science ®Google Scholar
• Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest.116(7), 1776–1783 (2006).
   PubMed Web of Science ®Google Scholar
• Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology144(12), 5179–5183 (2003).
   PubMed Web of Science ®Google Scholar
• Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMP-activated protein kinase system. FEBS Letters546(1), 113–120 (2003).
   PubMed Web of Science ®Google Scholar
• Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J. Appl. Physiol.91(3), 1017–1028 (2001).
   PubMed Web of Science ®Google Scholar
• Carling D. The AMP-activated protein kinase cascade – a unifying system for energy control. Trends Biochem. Sci.29(1), 18–24 (2004).
   PubMed Web of Science ®Google Scholar
• Hardie DG. The AMP-activated protein kinase pathway – new players upstream and downstream. J. Cell. Sci.117(23), 5479–5487 (2004).
   Google Scholar
• Hawley SA, Pan DA, Mustard KJ et al. Calmodulin-dependent protein kinase kinase-[β] is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab.2(1), 9–19 (2005).
   Google Scholar
• Hurley RL, Anderson KA, Franzone JM et al. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem.280(32), 29060–29066 (2005).
   PubMed Web of Science ®Google Scholar
• Woods A, Dickerson K, Heath R et al. Ca2+/calmodulin-dependent protein kinase kinase-[β] acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism2(1), 21–33 (2005).
   PubMed Web of Science ®Google Scholar
• Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. Am. J. Physiol. Endocrinol. Metab.277(1), E1–10 (1999).
   PubMed Web of Science ®Google Scholar
• Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur. J. Biochem.229(2), 558–565 (1995).
   PubMedGoogle Scholar
• Iglesias MA, Ye J-M, Frangioudakis G et al. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes51(10), 2886–2894 (2002).
   PubMed Web of Science ®Google Scholar
• Chang PY, Jensen J, Printz RL et al. Overexpression of hexokinase II in transgenic mice. Evidence that increased phosphorylation augments muscle glucose uptake. J. Biol. Chem.271(25), 14834–14839 (1996).
   PubMed Web of Science ®Google Scholar
• Zierath JR, Tsao TS, Stenbit AE et al. Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J. Biol. Chem.273(33), 20910–20915 (1998).
   PubMedGoogle Scholar
• Cuthbertson DJ, Babraj JA, Mustard KJW et al. AICAR acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes (2007) (Epub ahead of print).
   Google Scholar
• Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell,7(5), 1085–1094 (2001).
   PubMed Web of Science ®Google Scholar
• Koh H-J, Arnolds DE, Fujii N et al. Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol. Cell. Biol.26(22), 8217–8227 (2006).
   PubMedGoogle Scholar
• Barnes BR, Marklund S, Steiler TL et al. The 5´-AMP-activated protein kinase γ3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem.279(37), 38441–38447 (2004).
   PubMed Web of Science ®Google Scholar
• Jorgensen SB, Viollet B, Andreelli F et al. Knockout of the α2 but not α1 5´-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-{β}-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem.279(2), 1070–1079 (2004).
   PubMed Web of Science ®Google Scholar
• Sakamoto K, McCarthy A, Smith D et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J.24(10), 1810–1820 (2005).
   PubMed Web of Science ®Google Scholar
• Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. Endocrinol. Metab.270(2), E299–E304 (1996).
   PubMed Web of Science ®Google Scholar
• Winder WW, Wilson HA, Hardie DG et al. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J. Appl. Physiol.82(1), 219–225 (1997).
   PubMedGoogle Scholar
• Trumble G, Smith M, Winder W. Purification and characterization of rat skeletal muscle acetyl-CoA carboxylase. Eur. J. Biochem.231(1), 192–198 (1995).
   Google Scholar
• Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. Endocrinol. Metab.276(1), E1–18 (1999).
   PubMed Web of Science ®Google Scholar
• Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. Endocrinol. Metab.273(6), E1107–E1112 (1997).
   PubMed Web of Science ®Google Scholar
• Merrill GF, Kurth EJ, Rasmussen BB, Winder WW. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle. J. Appl. Physiol.85(5), 1909–1914 (1998).
   Google Scholar
• Brownsey RW, Boone AN, Elliott JE, Kulpa JE, Lee WM. Regulation of acetyl-CoA carboxylase. Biochem. Soc. Trans.34(Pt 2), 223–227 (2006).
   PubMed Web of Science ®Google Scholar
• Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science291(5513), 2613–2616 (2001).
   PubMed Web of Science ®Google Scholar
• Daval M, Foufelle F, Ferre P. Functions of AMP-activated protein kinase in adipose tissue. J. Physiol.574(1), 55–62 (2006).
   PubMed Web of Science ®Google Scholar
• Richards SK, Parton LE, Leclerc I, Rutter GA, Smith RM. Over-expression of AMP-activated protein kinase impairs pancreatic β-cell function in vivo. J. Endocrinol.187(2), 225–235 (2005).
   Google Scholar
• Kefas BA, Cai Y, Ling Z et al. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J. Mol. Endocrinol.30(2), 151–161 (2003).
   PubMed Web of Science ®Google Scholar
• Rutter GA, Da Silva Xavier G, Leclerc I. Roles of 5´-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem. J.375(1), 1–16 (2003).
   PubMed Web of Science ®Google Scholar
• Minokoshi Y, Alquier T, Furukawa N et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature428(6982), 569–574 (2004).
   PubMed Web of Science ®Google Scholar
• Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab.1(1), 15–25 (2005).
   PubMed Web of Science ®Google Scholar
• Mahlapuu M, Johansson C, Lindgren K et al. Expression profiling of the γ-subunit isoforms of AMP-activated protein kinase suggests a major role for γ3 in white skeletal muscle. Am. J. Physiol. Endocrinol. Metab.286(2), E194–E200 (2004).
   Google Scholar
• Estrade M, Vignon X, Rock E, Monin G. Glycogen hyperaccumulation in white muscle fibres of RN- carrier pigs. A biochemical and ultrastructural study. Comp. Biochem. Physiol. B104(2), 321–326 (1993).
   Google Scholar
• Milan D, Jeon J-T, Looft C et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science288(5469), 1248–1251 (2000).
   PubMed Web of Science ®Google Scholar
• Lebret B, Le Roy P, Monin G et al. Influence of the three RN genotypes on chemical composition, enzyme activities, and myofiber characteristics of porcine skeletal muscle. J. Anim Sci.77(6), 1482–1489 (1999).
   PubMed Web of Science ®Google Scholar
• Buhl ES, Jessen N, Schmitz O et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes50(1), 12–17 (2001).
   Google Scholar
• Wright DC, Geiger PC, Holloszy JO, Han DH. Contraction- and hypoxia-stimulated glucose transport is mediated by a Ca2+-dependent mechanism in slow-twitch rat soleus muscle. Am. J. Physiol. Endocrinol. Metab.288(6), E1062–E1066 (2005).
   Google Scholar
• Fritz T, Kitz Krämer D, Karlsson HKR et al. Low-intensity exercise increases skeletal muscle protein expression of PPARδ and UCP3 in Type 2 diabetic patients Diabet. Metab. Res. Rev.22(6), 492–498 (2006).
   PubMed Web of Science ®Google Scholar
• Long YC, Barnes BR, Mahlapuu M et al. Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle. Diabetologia48(11), 2354–2364 (2005).
   Google Scholar
• Nilsson EC, Long YC, Martinsson S et al. Opposite transcriptional regulation in skeletal muscle of AMP-activated protein kinase γ3 R225Q transgenic versus knock-out mice. J. Biol. Chem.281(11), 7244–7252 (2006).
   Google Scholar
• Long YC, Glund S, Garcia-Roves PM, Zierath JR. Calcineurin regulates skeletal muscle metabolism via coordinated changes in gene expression. J. Biol. Chem.282(3), 1607–1614 (2007).
   PubMedGoogle Scholar